In Brief

GNC outperforming, issuing shares; Vitacost emerges from strategic review; Fleminger’s green tea QHC remanded back to FDA; supplement firm Modern Products unaware of GMPs; more news In Brief.

With its fiscal 2012 first quarter still in progress, [GNC Holdings Inc.]expects to beat its previously stated earnings-per-share projection of 49 cents, which was up from 33 cents per share in the year-ago quarter. The supplement retailer said March 12 its revised guidance stems from its same store sales performance in January and February, which GNC expected would increase between 8% and 9% in the quarter. Pittsburgh-based GNC also announced March 13 a secondary offering of 17 million shares of class A common stock that will be priced at $33.50 each; during the firm’s initial public offering last April, shares were priced at $16 Also see "In Brief" - Pink Sheet, 11 April, 2011..

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Compliance